Book contents
- Textbook of Clinical Management of Club Drugs and Novel Psychoactive Substances
- Textbook of Clinical Management of Club Drugs and Novel Psychoactive Substances
- Copyright page
- Contents
- Acknowledgements
- Part I Introduction and Background
- Part II Drugs with Primarily Depressant Effects
- Chapter 3 Gamma-Hydroxybutyrate (GHB) and Gamma-Butyrolactone (GBL)
- Chapter 4 New Benzodiazepine Novel Psychoactive Substances
- Chapter 5 Synthetic Opioid Novel Psychoactive Substances (Fentanyl and Non-fentanyl)
- Chapter 6 Ketamine and Other Novel Psychoactive Substances with Dissociative Effects
- Chapter 7 Nitrous Oxide (N2O)
- Part III Drugs with Primarily Stimulant Effects
- Part IV Drugs with Primarily Hallucinogenic Effects
- Part V Synthetic Cannabinoid Receptor Agonists
- Part VI Concluding Remarks
- Index
- References
Chapter 4 - New Benzodiazepine Novel Psychoactive Substances
from Part II - Drugs with Primarily Depressant Effects
Published online by Cambridge University Press: 06 October 2022
- Textbook of Clinical Management of Club Drugs and Novel Psychoactive Substances
- Textbook of Clinical Management of Club Drugs and Novel Psychoactive Substances
- Copyright page
- Contents
- Acknowledgements
- Part I Introduction and Background
- Part II Drugs with Primarily Depressant Effects
- Chapter 3 Gamma-Hydroxybutyrate (GHB) and Gamma-Butyrolactone (GBL)
- Chapter 4 New Benzodiazepine Novel Psychoactive Substances
- Chapter 5 Synthetic Opioid Novel Psychoactive Substances (Fentanyl and Non-fentanyl)
- Chapter 6 Ketamine and Other Novel Psychoactive Substances with Dissociative Effects
- Chapter 7 Nitrous Oxide (N2O)
- Part III Drugs with Primarily Stimulant Effects
- Part IV Drugs with Primarily Hallucinogenic Effects
- Part V Synthetic Cannabinoid Receptor Agonists
- Part VI Concluding Remarks
- Index
- References
Summary
Benzodiazepine misuse is a worldwide public health concern that is associated with a number of concerning consequences.1 Whereas in the past, the misuse of benzodiazepines was linked to the diversion of medicinal benzodiazepines, currently synthetic processes for benzodiazepine manufacture are freely available, and many illicitly manufactured benzodiazepines have been reported in recent years.
- Type
- Chapter
- Information
- Textbook of Clinical Management of Club Drugs and Novel Psychoactive SubstancesNEPTUNE Clinical Guidance, pp. 65 - 77Publisher: Cambridge University PressPrint publication year: 2022